| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CKO_01332 | CKO_01651 | CKO_01332 | CKO_01651 | Hypothetical protein; COG: NOG06197 non supervised orthologous group; Psort location: CytoplasmicMembrane, score:10.00. | Hypothetical protein; COG: COG3895 Predicted periplasmic protein. | 0.710 |
| CKO_01332 | CKO_01952 | CKO_01332 | CKO_01952 | Hypothetical protein; COG: NOG06197 non supervised orthologous group; Psort location: CytoplasmicMembrane, score:10.00. | Hypothetical protein; COG: COG5633 Predicted periplasmic lipoprotein. | 0.769 |
| CKO_01332 | CKO_02318 | CKO_01332 | CKO_02318 | Hypothetical protein; COG: NOG06197 non supervised orthologous group; Psort location: CytoplasmicMembrane, score:10.00. | Hypothetical protein; COG: NOG10254 non supervised orthologous group. | 0.626 |
| CKO_01332 | CKO_02690 | CKO_01332 | CKO_02690 | Hypothetical protein; COG: NOG06197 non supervised orthologous group; Psort location: CytoplasmicMembrane, score:10.00. | Hypothetical protein; COG: NOG09846 non supervised orthologous group; Psort location: Cytoplasmic, score:8.96. | 0.770 |
| CKO_01332 | CKO_03087 | CKO_01332 | CKO_03087 | Hypothetical protein; COG: NOG06197 non supervised orthologous group; Psort location: CytoplasmicMembrane, score:10.00. | Hypothetical protein; COG: COG3678 P pilus assembly/Cpx signaling pathway, periplasmic inhibitor/zinc-resistance associated protein; Psort location: Periplasmic, score:10.00. | 0.771 |
| CKO_01332 | CKO_03401 | CKO_01332 | CKO_03401 | Hypothetical protein; COG: NOG06197 non supervised orthologous group; Psort location: CytoplasmicMembrane, score:10.00. | Hypothetical protein; KEGG: ece:Z5988 8.8e-101 putative lipoate-protein ligase A K03800:K07186; COG: COG3726 Uncharacterized membrane protein affecting hemolysin expression. | 0.681 |
| CKO_01332 | CKO_04644 | CKO_01332 | CKO_04644 | Hypothetical protein; COG: NOG06197 non supervised orthologous group; Psort location: CytoplasmicMembrane, score:10.00. | Hypothetical protein; COG: NOG12178 non supervised orthologous group. | 0.766 |
| CKO_01332 | ftsN | CKO_01332 | CKO_03061 | Hypothetical protein; COG: NOG06197 non supervised orthologous group; Psort location: CytoplasmicMembrane, score:10.00. | Hypothetical protein; Essential cell division protein that activates septal peptidoglycan synthesis and constriction of the cell. Acts on both sides of the membrane, via interaction with FtsA in the cytoplasm and interaction with the FtsQBL complex in the periplasm. These interactions may induce a conformational switch in both FtsA and FtsQBL, leading to septal peptidoglycan synthesis by FtsI and associated synthases. | 0.667 |
| CKO_01332 | lpoB | CKO_01332 | CKO_01951 | Hypothetical protein; COG: NOG06197 non supervised orthologous group; Psort location: CytoplasmicMembrane, score:10.00. | Hypothetical protein; Regulator of peptidoglycan synthesis that is essential for the function of penicillin-binding protein 1B (PBP1b). | 0.740 |
| CKO_01332 | mzrA | CKO_01332 | CKO_04498 | Hypothetical protein; COG: NOG06197 non supervised orthologous group; Psort location: CytoplasmicMembrane, score:10.00. | Hypothetical protein; Modulates the activity of the EnvZ/OmpR two-component regulatory system, probably by directly modulating EnvZ enzymatic activity and increasing stability of phosphorylated OmpR. | 0.771 |
| CKO_01651 | CKO_01332 | CKO_01651 | CKO_01332 | Hypothetical protein; COG: COG3895 Predicted periplasmic protein. | Hypothetical protein; COG: NOG06197 non supervised orthologous group; Psort location: CytoplasmicMembrane, score:10.00. | 0.710 |
| CKO_01651 | CKO_01952 | CKO_01651 | CKO_01952 | Hypothetical protein; COG: COG3895 Predicted periplasmic protein. | Hypothetical protein; COG: COG5633 Predicted periplasmic lipoprotein. | 0.669 |
| CKO_01651 | CKO_02318 | CKO_01651 | CKO_02318 | Hypothetical protein; COG: COG3895 Predicted periplasmic protein. | Hypothetical protein; COG: NOG10254 non supervised orthologous group. | 0.449 |
| CKO_01651 | CKO_02690 | CKO_01651 | CKO_02690 | Hypothetical protein; COG: COG3895 Predicted periplasmic protein. | Hypothetical protein; COG: NOG09846 non supervised orthologous group; Psort location: Cytoplasmic, score:8.96. | 0.660 |
| CKO_01651 | CKO_03087 | CKO_01651 | CKO_03087 | Hypothetical protein; COG: COG3895 Predicted periplasmic protein. | Hypothetical protein; COG: COG3678 P pilus assembly/Cpx signaling pathway, periplasmic inhibitor/zinc-resistance associated protein; Psort location: Periplasmic, score:10.00. | 0.750 |
| CKO_01651 | CKO_03401 | CKO_01651 | CKO_03401 | Hypothetical protein; COG: COG3895 Predicted periplasmic protein. | Hypothetical protein; KEGG: ece:Z5988 8.8e-101 putative lipoate-protein ligase A K03800:K07186; COG: COG3726 Uncharacterized membrane protein affecting hemolysin expression. | 0.458 |
| CKO_01651 | CKO_04644 | CKO_01651 | CKO_04644 | Hypothetical protein; COG: COG3895 Predicted periplasmic protein. | Hypothetical protein; COG: NOG12178 non supervised orthologous group. | 0.756 |
| CKO_01651 | ftsN | CKO_01651 | CKO_03061 | Hypothetical protein; COG: COG3895 Predicted periplasmic protein. | Hypothetical protein; Essential cell division protein that activates septal peptidoglycan synthesis and constriction of the cell. Acts on both sides of the membrane, via interaction with FtsA in the cytoplasm and interaction with the FtsQBL complex in the periplasm. These interactions may induce a conformational switch in both FtsA and FtsQBL, leading to septal peptidoglycan synthesis by FtsI and associated synthases. | 0.519 |
| CKO_01651 | lpoB | CKO_01651 | CKO_01951 | Hypothetical protein; COG: COG3895 Predicted periplasmic protein. | Hypothetical protein; Regulator of peptidoglycan synthesis that is essential for the function of penicillin-binding protein 1B (PBP1b). | 0.630 |
| CKO_01651 | mzrA | CKO_01651 | CKO_04498 | Hypothetical protein; COG: COG3895 Predicted periplasmic protein. | Hypothetical protein; Modulates the activity of the EnvZ/OmpR two-component regulatory system, probably by directly modulating EnvZ enzymatic activity and increasing stability of phosphorylated OmpR. | 0.726 |